Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphoma (vol 37, pg 1107, 2023)

被引：1
|
作者：
Muhsen, Ibrahim N.
Hill, LaQuisa C.
Ramos, Carlos A.
机构：
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2024年 / 38卷 / 01期
关键词：
D O I：
10.1016/j.hoc.2023.11.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1121 / 1121
页数：1
相关论文
共 50 条
  • [31] Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight
    Craig A. Land
    Phillip R. Musich
    Dalia Haydar
    Giedre Krenciute
    Qian Xie
    Journal of Translational Medicine, 18
  • [32] Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight
    Land, Craig A.
    Musich, Phillip R.
    Haydar, Dalia
    Krenciute, Giedre
    Xie, Qian
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [33] Switchable chimeric antigen receptor T cells: a novel universal chimeric antigen receptor platform for a safe control of T-cell activation
    Arcangeli, Silvia
    Magnani, Chiara F.
    Tettamanti, Sarah
    Biagi, Ettore
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S174 - S177
  • [34] Commentary: Chimeric Antigen Receptor T-Cell Therapy: Updates in Glioblastoma Treatment GLIOBLASTOMA: A CASE FOR CHIMERIC ANTIGEN RECEPTOR T CELLS
    Yu, Xiaoling
    Curry, William T.
    Gerstner, Elizabeth R.
    Cahill, Daniel P.
    Nahed, Brian V.
    Maus, Marcela V.
    Carter, Bob S.
    Choi, Bryan D.
    NEUROSURGERY, 2021, 89 (01) : E68 - E69
  • [35] Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas
    Scarfo, Irene
    Ormhoj, Maria
    Frigault, Matthew J.
    Castano, Ana P.
    Lorrey, Selena
    Bouffard, Amanda A.
    van Scoyk, Alexandria
    Rodig, Scott J.
    Shay, Alexandra J.
    Aster, Jon C.
    Preffer, Frederic, I
    Weinstock, David M.
    Maus, Marcela, V
    BLOOD, 2018, 132 (14) : 1495 - 1506
  • [36] Total costs of chimeric antigen receptor T-cell immunotherapy (vol 4, pg 994, 2018)
    Prasad, Vinay
    JAMA ONCOLOGY, 2018, 4 (10) : 1439 - 1439
  • [37] Allogeneic Stem Cell Transplantation and Chimeric Antigen Receptor (CAR) T-Cell Therapy for the Treatment of Non-Hodgkin Lymphoma
    Hunter, Bradley D.
    Chen, Yi-Bin
    Jacobson, Caron A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 33 (04) : 687 - +
  • [38] Chimeric Antigen Receptor T-Cell Therapy for Companion Canines with Spontaneous B-Cell Non-Hodgkin Lymphoma
    O'Connor, Colleen M.
    Olivares, Simon
    Ang, Sonny
    Champlin, Richard E.
    Wilson-Robles, Heather M.
    Cooper, Laurence J. N.
    MOLECULAR THERAPY, 2013, 21 : S249 - S249
  • [39] Maintaining a fit T-cell compartment: lymphoma treatment sequencing in the era of chimeric antigen receptor T-cell therapies
    Dickinson, Michael
    Weinkove, Robert
    INTERNAL MEDICINE JOURNAL, 2019, 49 (10) : 1338 - 1338
  • [40] Nonviral RNA chimeric antigen receptor-modified T cells in patients with Hodgkin lymphoma
    Svoboda, Jakub
    Rheingold, Susan R.
    Gill, Saar I.
    Grupp, Stephan A.
    Lacey, Simon F.
    Kulikovskaya, Irina
    Suhoski, Megan M.
    Melenhorst, J. Joseph
    Loudon, Brandon
    Mato, Anthony R.
    Nasta, Sunita Dwivedy
    Landsburg, Daniel J.
    Youngman, Matthew R.
    Levine, Bruce L.
    Porter, David L.
    June, Carl H.
    Schuster, Stephen J.
    BLOOD, 2018, 132 (10) : 1022 - 1026
12345